Several serum biomarkers, including Cytokeratin 19 Fragment (CYFRA 21-1), Carcinoembryonic Antigen (CEA), and Interleukin-6 (IL-6), have been investigated for their potential in diagnosing NSCLC [6,7,8]. This evidence concerns the gene IL6 and non-small cell lung carcinoma.